항혈전제 시장은 2023-2028년 217억 8,380만 달러 규모로 예측기간 동안 7.68%의 CAGR로 성장할 것으로 예상됩니다.
본 보고서는 항혈전제 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 포함한 벤더 분석 등의 정보를 전해드립니다.
현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 응고 장애의 유병률 증가, 새로운 경구용 항응고제 도입, 강력한 R&D 파이프라인 구축 등이 시장을 주도하고 있습니다.
| 시장 범위 |
| 기준 연도 |
2024 |
| 종료 연도 |
2028 |
| 예측 기간 |
2024-2028 |
| 성장 모멘텀 |
가속 |
| 전년 대비 2024년 |
7.32% |
| CAGR |
7.68% |
| 증분 금액 |
217억 8,380만 달러 |
이 보고서는 향후 몇 년 동안 항혈전제 시장 성장을 주도할 주요 요인 중 하나로 항응고 해독제의 등장을 꼽았습니다. 또한, 시장 중심 기업의 전략적 제휴 및 인수, 시장 중심 신흥국 시장 개척이 시장의 큰 수요를 창출할 것으로 예상했습니다.
목차
제1장 주요 요약
제2장 시장 상황
제3장 시장 규모 평가
- 시장 정의
- 시장 부문 분석
- 시장 규모 2023
- 시장 전망 2023-2028
제4장 시장 규모 실적
- 세계 항혈전제 시장 2018-2022
- 투여 경로별 부문 분석 2018-2022
- 유통 채널별 부문 분석 2018-2022
- 지역별 부문 분석 2018-2022
- 국가별 부문 분석 2018-2022
제5장 Five Forces 분석
- Five Forces 요약
- 구매자의 교섭력
- 공급 기업의 교섭력
- 신규 참여업체의 위협
- 대체품의 위협
- 경쟁의 위협
- 시장 상황
제6장 시장 세분화 : 투여 경로별
- 시장 세분화
- 비교 : 투여 경로별
- 경구 : 시장 규모와 예측 2023-2028
- 주사 가능 : 시장 규모와 예측 2023-2028
- 시장 기회 : 투여 경로별
제7장 시장 세분화 : 유통 채널별
- 시장 세분화
- 비교 : 유통 채널별
- 병원 약국 : 시장 규모와 예측 2023-2028
- 소매 약국 : 시장 규모와 예측 2023-2028
- 온라인 약국 : 시장 규모와 예측 2023-2028
- 시장 기회 : 유통 채널별
제8장 고객 상황
제9장 지역별 상황
- 지역별 세분화
- 지역별 비교
- 북미 : 시장 규모와 예측 2023-2028
- 유럽 : 시장 규모와 예측 2023-2028
- 아시아 : 시장 규모와 예측 2023-2028
- 세계 기타 지역 : 시장 규모와 예측 2023-2028
- 미국 : 시장 규모와 예측 2023-2028
- 독일 : 시장 규모와 예측 2023-2028
- 영국 : 시장 규모와 예측 2023-2028
- 일본 : 시장 규모와 예측 2023-2028
- 캐나다 : 시장 규모와 예측 2023-2028
- 시장 기회 : 지역 상황별
제10장 촉진요인, 과제, 기회, 억제요인
- 시장 성장 촉진요인
- 시장 과제
- 성장 촉진요인과 과제의 영향
- 시장 기회·억제요인
제11장 경쟁 상황
제12장 경쟁 분석
- 기업 개요
- 기업의 시장 포지셔닝
- Aspen Pharmacare Holdings Ltd.
- AstraZeneca Plc
- Bayer AG
- Boehringer Ingelheim International GmbH
- Bristol Myers Squibb Co.
- Daiichi Sankyo Co. Ltd.
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- Fresenius Kabi AG
- Hikma Pharmaceuticals Plc
- Novartis AG
- Otsuka Pharmaceutical Co. Ltd.
- Sanofi SA
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
제13장 부록
ksm
The antithrombotic drugs market is forecasted to grow by USD 21783.8 mn during 2023-2028, accelerating at a CAGR of 7.68% during the forecast period. The report on the antithrombotic drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of coagulation disorders, introduction of novel oral anticoagulants, and strong R and D pipeline in building.
Technavio's antithrombotic drugs market is segmented as below:
| Market Scope |
|---|
| Base Year | 2024 |
| End Year | 2028 |
| Series Year | 2024-2028 |
| Growth Momentum | Accelerate |
| YOY 2024 | 7.32% |
| CAGR | 7.68% |
| Incremental Value | $21783.8mn |
By Route Of Administration
By Distribution Channel
- Hospital pharmacy
- Retail pharmacy
- Online pharmacy
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the advent of anticoagulant antidotes as one of the prime reasons driving the antithrombotic drugs market growth during the next few years. Also, strategic partnerships and acquisitions of companies in market focus and growing new developments in market focus will lead to sizable demand in the market.
The report on the antithrombotic drugs market covers the following areas:
- Antithrombotic drugs market sizing
- Antithrombotic drugs market forecast
- Antithrombotic drugs market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antithrombotic drugs market vendors that include AbbVie Inc., Aspen Pharmacare Holdings Ltd., AstraZeneca PLC, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Fresenius Kabi AG, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Otsuka Pharmaceutical Co. Ltd., Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the antithrombotic drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 2.2 Market characteristics
- Market characteristics analysis
- 2.3 Value chain analysis
3 Market Sizing
- 3.1 Market definition
- Offerings of companies included in the market definition
- 3.2 Market segment analysis
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global Antithrombotic Drugs Market 2018 - 2022
- Historic Market Size - Data Table on Global Antithrombotic Drugs Market 2018 - 2022 ($ million)
- 4.2 Route of Administration segment analysis 2018 - 2022
- Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
- 4.3 Distribution Channel segment analysis 2018 - 2022
- Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
- 4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- 4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Route of Administration
- 6.1 Market segments
- Chart on Route of Administration - Market share 2023-2028 (%)
- Data Table on Route of Administration - Market share 2023-2028 (%)
- 6.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- 6.3 Oral - Market size and forecast 2023-2028
- Chart on Oral - Market size and forecast 2023-2028 ($ million)
- Data Table on Oral - Market size and forecast 2023-2028 ($ million)
- Chart on Oral - Year-over-year growth 2023-2028 (%)
- Data Table on Oral - Year-over-year growth 2023-2028 (%)
- 6.4 Injectable - Market size and forecast 2023-2028
- Chart on Injectable - Market size and forecast 2023-2028 ($ million)
- Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
- Chart on Injectable - Year-over-year growth 2023-2028 (%)
- Data Table on Injectable - Year-over-year growth 2023-2028 (%)
- 6.5 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
7 Market Segmentation by Distribution Channel
- 7.1 Market segments
- Chart on Distribution Channel - Market share 2023-2028 (%)
- Data Table on Distribution Channel - Market share 2023-2028 (%)
- 7.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- 7.3 Hospital pharmacy - Market size and forecast 2023-2028
- Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
- Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
- Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
- Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
- 7.4 Retail pharmacy - Market size and forecast 2023-2028
- Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
- Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
- Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
- Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
- 7.5 Online pharmacy - Market size and forecast 2023-2028
- Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
- Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
- Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
- Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
- 7.6 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
- 8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
- 9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 9.8 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 9.9 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 9.10 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)
- 9.11 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 9.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 10.4 Market opportunities/restraints
11 Competitive Landscape
- 11.1 Overview
- 11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 11.3 Landscape disruption
- Overview on factors of disruption
- 11.4 Industry risks
- Impact of key risks on business
12 Competitive Analysis
- 12.1 Companies profiled
- 12.2 Market positioning of companies
- Matrix on companies position and classification
- 12.3 Aspen Pharmacare Holdings Ltd.
- Aspen Pharmacare Holdings Ltd. - Overview
- Aspen Pharmacare Holdings Ltd. - Business segments
- Aspen Pharmacare Holdings Ltd. - Key offerings
- Aspen Pharmacare Holdings Ltd. - Segment focus
- 12.4 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- 12.5 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- 12.6 Boehringer Ingelheim International GmbH
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Product / Service
- Boehringer Ingelheim International GmbH - Key news
- Boehringer Ingelheim International GmbH - Key offerings
- 12.7 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- 12.8 Daiichi Sankyo Co. Ltd.
- Daiichi Sankyo Co. Ltd. - Overview
- Daiichi Sankyo Co. Ltd. - Product / Service
- Daiichi Sankyo Co. Ltd. - Key news
- Daiichi Sankyo Co. Ltd. - Key offerings
- 12.9 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key news
- Eli Lilly and Co. - Key offerings
- 12.10 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- 12.11 Fresenius Kabi AG
- Fresenius Kabi AG - Overview
- Fresenius Kabi AG - Business segments
- Fresenius Kabi AG - Key offerings
- Fresenius Kabi AG - Segment focus
- 12.12 Hikma Pharmaceuticals Plc
- Hikma Pharmaceuticals Plc - Overview
- Hikma Pharmaceuticals Plc - Business segments
- Hikma Pharmaceuticals Plc - Key news
- Hikma Pharmaceuticals Plc - Key offerings
- Hikma Pharmaceuticals Plc - Segment focus
- 12.13 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- 12.14 Otsuka Pharmaceutical Co. Ltd.
- Otsuka Pharmaceutical Co. Ltd. - Overview
- Otsuka Pharmaceutical Co. Ltd. - Product / Service
- Otsuka Pharmaceutical Co. Ltd. - Key offerings
- 12.15 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- 12.16 Teva Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key news
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Segment focus
- 12.17 Viatris Inc.
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 13.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 13.4 Research methodology
- 13.5 Data procurement
- 13.6 Data validation
- 13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 13.8 Data synthesis
- 13.9 360 degree market analysis
- 360 degree market analysis
- 13.10 List of abbreviations
